rxstat › Shortages › Conjugated Estrogens

Conjugated Estrogens shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Conjugated Estrogens is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 4
Reports on file
13

Reports by product

Anticipated
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA ULC
DIN 02043440 · Disruption of the manufacture of the drug.
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA ULC
DIN 02043440 · ended Feb 21, 2026 · Disruption of the manufacture of the drug.
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA ULC
DIN 02043440 · ended Oct 7, 2025 · Disruption of the manufacture of the drug.
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA ULC
DIN 02043440 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
PREMARIN
0.625MG · TABLET (EXTENDED-RELEASE) · PFIZER CANADA ULC
DIN 02414686 · ended Aug 12, 2024 · Disruption of the manufacture of the drug.
Resolved
PREMARIN
1.25MG · TABLET (EXTENDED-RELEASE) · PFIZER CANADA ULC
DIN 02414694 · ended Jul 11, 2024 · Demand increase for the drug.
Resolved
PREMARIN INTRAVENOUS
25MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02043386 · ended Jun 1, 2023 · Demand increase for the drug.
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA ULC
DIN 02043440 · ended Dec 7, 2021 · Disruption of the manufacture of the drug.
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA INC
DIN 02043440 · ended Dec 17, 2018 · Demand increase for the drug.
Discontinued
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA INC
DIN 02043440
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA INC
DIN 02043440 · ended May 16, 2018 · Other (Please describe in comments)
Resolved
PREMARIN VAGINAL CREAM
0.625MG · CREAM · PFIZER CANADA INC
DIN 02043440 · ended Nov 21, 2017 · Disruption of the manufacture of the drug.

Showing 12 of 13 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Conjugated Estrogens to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Conjugated Estrogens is classified under “ESTROGENS” (ATC G03CA).

Recent changes

Common questions

When will Conjugated Estrogens be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Conjugated Estrogens in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (estrogens)

Partial shortageEstradiol6 of 24 reported products affected · est. return Aug 20, 2026No current shortageBazedoxifene Conjugated Estrogens

All estrogens shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.